Care Partners of Memorial Sloan Kettering Cancer Center (MSK Care Partners) are healthcare organizations that are committed to working with MSK toward a shared goal: ensuring more patients have access to integrated, subspecialized, high-quality cancer care and delivering the latest and most effective cancer treatments to their communities.
These healthcare institutions have a durable, institutional-level relationship with MSK and have achieved concordance with MSK benchmarks by adopting the MSK Standards of Care™ following an intensive review of their cancer program infrastructure, processes, and outcomes.
Program goals
- To offer the best cancer care to more patients and support MSK’s mission of ending cancer for life
- To serve as a platform for innovative clinical trials
- To expand MSK’s Standards of Care™ and positive patient outcomes to a wider community of patients
MSK Care Partners receive access to state-of-the-art clinical advancements and innovations to improve care delivery.
Dedicated MSK staff resources, operating committees, and advisory councils.
Support to bolster their research and clinical trials infrastructure.
Access to a variety of educational opportunities with MSK clinicians.
Benefits of being an MSK Care Partner
Joint governance and program development
- Member-specific Joint Operating Committee (JOC)
- Oncology Physician Advisory Council (OPAC) to oversee changes in practice and implementation of Standards of Care™
- Dedicated MSK relationship manager to support activities of dedicated MSK site director, JOC, and OPAC
Education and knowledge transfer
- Grand Rounds, practice discussions, and case conferences
- Nursing and APP education
- MSK observerships and adjunct appointments for select full-time cancer program physicians
Clinical excellence and innovation
- Access to state-of-the-art Standards of Care™ that outpace changes to nationwide recommendations
- Recommended resources and capabilities to improve infrastructure
- Serve as incubator and means for disseminating innovative care delivery paradigms developed at MSK
Research and clinical trials
- Research, IRB, and clinical trials infrastructure
- MSK trials onsite (following assessment process)
- Access to peer-to-peer consultations, collaborations, and MSK Care Partners-focused research symposia
Program growth
- Program improvement and enhancement, including differentiation through subspecialized delivery models and physician recruitment
- Advising and guidance related to new program development, including but not limited to bone marrow transplant and immuno-oncology
Care Partner co-branding
- Co-branded, subspecialized, and integrated clinical program that accelerates the partner’s journey to a destination oncology program
- Ability to market branded relationship and develop co-branded patient-facing materials
MSK Care Partners receive guidance from MSK clinicians to differentiate and expand their program offerings.
Becoming an MSK Care Partner
The process to become an MSK Care Partner begins with comprehensive due diligence, including market analysis and financial evaluation, and agreement on mutually acceptable terms and milestones. Next, partners undergo a robust Concordance assessment, encompassing Standards of Care™, resources and capabilities, clinical outcomes, and site visits.
Following the Concordance assessment, MSK and the potential partner will develop an alignment plan and timeline to close the gaps and achieve concordance, providing a clear roadmap and instilling confidence in the partnership.
Upon a mutually satisfactory conclusion and meeting concordance, MSK Care Partners receive access to branded marketing, facility co-branding, MSK guidelines and protocols, and educational and research support.
Annual reviews will be conducted to ensure ongoing concordance and support introduction of the latest and most effective approaches to cancer care based on scientific evidence.
For more information about MSK Care Partners or to learn how to become a partner, please contact MSKCarePartner@mskcc.org.